{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:58Z","timestamp":1791849778798,"version":"4.3.4"},"reference-count":34,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Early clearance of leukemic cells is a favorable prognostic indicator in childhood acute lymphoblastic leukemia (ALL). However, identification of residual leukemic cells by their morphologic features is subjective and lacks sensitivity. To improve estimates of leukemia clearance, we applied flow cytometric techniques capable of detecting 1 leukemic cell in 10\u2009000 or more normal cells and prospectively measured residual leukemia in bone marrow samples collected on day 19 of remission-induction chemotherapy from 248 children with newly diagnosed ALL. In 134 samples (54.0%), we identified at least 0.01% leukemic cells (0.01%-&amp;lt; 0.1% in 51 samples [20.6%], 0.1%-&amp;lt; 1% in 36 [14.5%], and \u2265 1% in 47 [19.0%]). Among 110 children treated within a single chemotherapy program, the 5-year mean \u00b1 SE cumulative incidence of relapse or failure to achieve remission was 32.2% \u00b1 6.5% for the 59 patients with 0.01% residual leukemic cells or greater on day 19 and 6.0% \u00b1 3.4% for the 51 patients with less than 0.01% leukemic cells (P\u2009&amp;lt;\u2009.001). The prognostic value of day-19 bone marrow status defined by flow cytometry was superior to that defined by morphologic studies and remained significant after adjustment for other clinical and biologic variables. Lack of detectable leukemic cells on day 19 was more closely associated with relapse-free survival than was lack of detectable residual disease at the end of remission induction (day 46). Thus, approximately half of the children with ALL achieve profound clearance of leukemic cells after 2 to 3 weeks of remission-induction chemotherapy, and these patients have an excellent treatment outcome.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0006","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":213,"title":["Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"100","author":[{"given":"Elaine","family":"Coustan-Smith","sequence":"first","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Sancho","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G.","family":"Behm","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Hancock","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem I.","family":"Razzouk","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston K.","family":"Rivera","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Rubnitz","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Sandlund","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Campana","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology-Oncology, Pathology, Biostatistics, St Jude Children's Research Hospital; and the University of Tennessee, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221425959400_B1","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood."},{"key":"2020021221425959400_B2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM199307293290504","article-title":"Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.","volume":"329","author":"Mahmoud","year":"1993","journal-title":"N Engl J Med."},{"key":"2020021221425959400_B3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.","volume":"338","author":"Evans","year":"1998","journal-title":"N Engl J Med."},{"key":"2020021221425959400_B4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics.","volume":"286","author":"Evans","year":"1999","journal-title":"Science."},{"key":"2020021221425959400_B5","first-page":"285","volume-title":"Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. American Society of Hematology Education Program","author":"Felix","year":"2000"},{"key":"2020021221425959400_B6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.leu.2402111","article-title":"International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000.","volume":"15","author":"Pui","year":"2001","journal-title":"Leukemia."},{"key":"2020021221425959400_B7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukemia\u2014current status and future perspectives.","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncol."},{"key":"2020021221425959400_B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83) [In German].","volume":"199","author":"Riehm","year":"1987","journal-title":"Klin Padiatr."},{"key":"2020021221425959400_B9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","article-title":"Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia.","volume":"86","author":"Gajjar","year":"1995","journal-title":"Blood."},{"key":"2020021221425959400_B10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2141.1997.1002914.x","article-title":"Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.","volume":"97","author":"Lilleyman","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021221425959400_B11","first-page":"2730","article-title":"Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.","volume":"92","author":"Schrappe","year":"1998","journal-title":"Blood."},{"key":"2020021221425959400_B12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood."},{"key":"2020021221425959400_B13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.1989.7.12.1807","article-title":"Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.","volume":"7","author":"Miller","year":"1989","journal-title":"J Clin Oncol."},{"key":"2020021221425959400_B14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","article-title":"Cytoreduction and prognosis in acute lymphoblastic leukemia\u2014the importance of early marrow response: report from the Childrens Cancer Group.","volume":"14","author":"Steinherz","year":"1996","journal-title":"J Clin Oncol."},{"key":"2020021221425959400_B15","doi-asserted-by":"crossref","first-page":"__","DOI":"10.1182\/blood.V100.1.43","article-title":"Persistence of lymphoblasts in bone marrow on day 15 and day 22-25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.","volume":"100","author":"Sandlund","year":"2002","journal-title":"Blood."},{"key":"2020021221425959400_B16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416","article-title":"Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance.","volume":"85","author":"Campana","year":"1995","journal-title":"Blood."},{"key":"2020021221425959400_B17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.leu.2401780","article-title":"New definition of remission in childhood acute lymphoblastic leukemia.","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia."},{"key":"2020021221425959400_B18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","article-title":"Minimal residual disease in leukaemia patients.","volume":"2","author":"Szczepanski","year":"2001","journal-title":"Lancet Oncol."},{"key":"2020021221425959400_B19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","article-title":"Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review.","volume":"80","author":"Gaynon","year":"1997","journal-title":"Cancer."},{"key":"2020021221425959400_B20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","article-title":"Detection of minimal residual disease in acute leukemia by flow cytometry.","volume":"38","author":"Campana","year":"1999","journal-title":"Cytometry."},{"key":"2020021221425959400_B21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.leu.2401459","article-title":"Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia.","volume":"13","author":"Neale","year":"1999","journal-title":"Leukemia."},{"key":"2020021221425959400_B22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia.","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet."},{"key":"2020021221425959400_B23","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.","volume":"96","author":"Coustan-Smith","year":"2000","journal-title":"Blood."},{"key":"2020021221425959400_B24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(00)00228-3","article-title":"Immunophenotyping of leukemia.","volume":"243","author":"Campana","year":"2000","journal-title":"J Immunol Methods."},{"key":"2020021221425959400_B25","first-page":"209","article-title":"Cytogenetics as a diagnostic aid for childhood hematological disorders. Conventional cytogenetic techniques, fluorescence in situ hybridization, comparative genomic hybridization.","volume-title":"Methods in Molecular Biology.","author":"Raimondi","year":"1998"},{"key":"2020021221425959400_B26","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.leu.2401224","article-title":"A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying translocations of pediatric acute lymphoblastic leukemia.","volume":"12","author":"Scurto","year":"1998","journal-title":"Leukemia."},{"key":"2020021221425959400_B27","first-page":"629","article-title":"Risk-adapted treatment for ALL\u2014findings from St Jude Children's Research Hospital.","volume-title":"Acute Leukemias VI: Prognostic Factors and Treatment Strategies.","author":"Pui","year":"1997"},{"key":"2020021221425959400_B28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.","volume":"92","author":"Pui","year":"1998","journal-title":"Blood."},{"key":"2020021221425959400_B29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia.","volume":"97","author":"Chen","year":"2001","journal-title":"Blood."},{"key":"2020021221425959400_B30","volume-title":"The Statistical Analysis of Failure Time Data.","author":"Kalbfleisch","year":"1980"},{"key":"2020021221425959400_B31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat."},{"key":"2020021221425959400_B32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.","volume":"95","author":"Panzer-Grumayer","year":"2000","journal-title":"Blood."},{"key":"2020021221425959400_B33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1309\/LXU4-Q7Q9-3YAB-4QE0","article-title":"Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.","volume":"114","author":"Rimsza","year":"2000","journal-title":"Am J Clin Pathol."},{"key":"2020021221425959400_B34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/1\/52\/1683911\/h81302000052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/1\/52\/1683911\/h81302000052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T02:47:54Z","timestamp":1581562074000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/1\/52\/133964\/Prognostic-importance-of-measuring-early-clearance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0006","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}